{
    "clinical_study": {
        "@rank": "110966", 
        "arm_group": [
            {
                "arm_group_label": "LFCO application", 
                "arm_group_type": "Experimental", 
                "description": "We made LFCO application(Lactobacillus Fermented Chamaecypris obtusa) containing cream to one side of patients' face to monitor effectiveness and safety in acne treatment."
            }, 
            {
                "arm_group_label": "TTO application", 
                "arm_group_type": "Active Comparator", 
                "description": "To compare effectiveness and safety of new LFCO, we applied existing TTO containing cream to the other side of face in the same patients"
            }
        ], 
        "brief_summary": {
            "textblock": "In an 8 week double blind randomized controlled split-face studies, we tried to compare the\n      clinical efficacy, safety and histopathological changes between Lactobacillus fermented\n      Chamaecypris obtusa (LFCO) and existing tea tree oil (TTO)\n\n      Basically, this is a split face study - one side of face randomly assigned was applied with\n      LFCO and the other side with TTO in same patients."
        }, 
        "brief_title": "Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acne Vulgaris", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "detailed_description": {
            "textblock": "Screening of natural compounds for the development of anti-acne therapeutic agents has been\n      steadily required considering various side effects of acne medications.However, previous\n      studies have mainly focused on experimental tests without clinical trials and\n      histopathological analysis.\n\n      To compare the clinical efficacy, safety and histopathological changes between Lactobacillus\n      fermented Chamaecypris obtusa (LFCO) and existing tea tree oil (TTO)\n\n      Total thirty four patients were instructed to apply 5 % LFCO to the involved areas of\n      randomly allocated side and 5 % TTO extract to the other side for 8 weeks in a double blind\n      split-face clinical trial."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 19-45\n\n          -  active acne lesions in both sides of face\n\n          -  available during study periods\n\n        Exclusion Criteria:\n\n          -  pregnancy, mental illness, intake of oral isotretinoin within 6 months, application\n             of the other oral or topical acne medications, chemical peeling or light based\n             treatments within 6 weeks."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01930565", 
            "org_study_id": "H-1209-069-427"
        }, 
        "intervention": [
            {
                "arm_group_label": "LFCO application", 
                "description": "Application of LFCO (Lactobacillus fermented Chamaecypris obtusa ) containing creams to one randomly selected face of patients to monitor its effectiveness and safety of acne treatments.", 
                "intervention_name": "LFCO application", 
                "intervention_type": "Other", 
                "other_name": "LFCO containg creams applied to acne lesions"
            }, 
            {
                "arm_group_label": "TTO application", 
                "description": "Application of TTO (Tea tree oil) containing creams to the other side of face of patients to monitor its effectiveness and safe compared with LFCO.", 
                "intervention_name": "TTO application", 
                "intervention_type": "Other", 
                "other_name": "TTO containg creams applied to acne lesions"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tea Tree Oil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acne", 
            "therapeutics", 
            "clinical trial", 
            "natural compound", 
            "Lactobacillus fermented Chamaecypris obtuse", 
            "tea tree oil"
        ], 
        "lastchanged_date": "August 22, 2013", 
        "link": {
            "url": "http://www.accessdata.fda.gov/scripts/cder/drugsatfda"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Department of Dermatology, Seoul National University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Clinical and Histological Effects Between Lactobacillus Fermented Chamaecypris Obtusa and Tea Tree Oil for the Treatment of Mild to Moderate Acne: an 8-week Double Blind, Randomized Controlled, Split-face Study", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Dae Hun Sun, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Compared to baseline, number inflammatory and non-inflammatory acne lesions were counted to check out the effectiveness & safety of two botanical compounds", 
            "measure": "Number of inflammatory and non-inflammatory acne lesions", 
            "safety_issue": "No", 
            "time_frame": "total 8 weeks after baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01930565"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Dae Hun Suh", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "22168326", 
                "citation": "Hayashi N, Kawashima M. Multicenter randomized controlled trial on combination therapy with 0.1% adapalene gel and oral antibiotics for acne vulgaris: comparison of the efficacy of adapalene gel alone and in combination with oral faropenem. J Dermatol. 2012 Jun;39(6):511-5. doi: 10.1111/j.1346-8138.2011.01450.x. Epub 2011 Dec 14."
            }, 
            {
                "PMID": "17314442", 
                "citation": "Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol. 2007 Jan-Feb;73(1):22-5."
            }
        ], 
        "secondary_outcome": [
            {
                "description": "Patients are required to report subjective assessments for comfortableness & efficacy for two creams they used", 
                "measure": "Patient's subjective assessments for comfortableness & efficacy", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks after baseline"
            }, 
            {
                "description": "Patients' sebum secretion from face was measured by sebumeter to detect sebum secretion changes after applying two components.", 
                "measure": "Sebum secretion assessment", 
                "safety_issue": "No", 
                "time_frame": "8 weeks after baseline"
            }, 
            {
                "description": "changes of tissue after application of two creams", 
                "measure": "Histopathologic analysis", 
                "safety_issue": "No", 
                "time_frame": "8 weeks after baseline"
            }, 
            {
                "description": "patients' reportings for severe side effects after application of two creams was monitored.", 
                "measure": "Adverse effects", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks after baseline"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}